Bazel International Ltd. has delivered impressive financial performance for the quarter and nine months ended December 31, 2025, demonstrating strong growth across key financial metrics. The registered non-banking financial company announced its unaudited results following a Board meeting held on February 13, 2026.

Strong Quarterly Performance

The company's standalone financial results for Q3FY26 showed remarkable improvement in profitability. Net profit surged to ₹52.19 lakhs compared to ₹21.76 lakhs in the corresponding quarter of the previous year, marking a substantial 139.89% year-on-year growth.

Nine-Month Financial Highlights

For the nine-month period ended December 31, 2025, Bazel International maintained its growth trajectory with net profit reaching ₹149.59 lakhs, representing a 24.81% increase from ₹119.87 lakhs in the corresponding period of FY25.

Revenue Composition and Operational Efficiency

The company's revenue growth was primarily driven by interest income, which constituted the major portion of operational revenue. Interest income for Q3FY26 stood at ₹114.05 lakhs compared to ₹76.27 lakhs in Q3FY25. The nine-month interest income reached ₹329.99 lakhs, up from ₹233.85 lakhs in the previous year.

Operational efficiency improved significantly with total expenses for Q3FY26 declining to ₹43.52 lakhs from ₹51.01 lakhs in Q3FY25. Employee benefits expense increased to ₹13.33 lakhs from ₹10.23 lakhs, while finance costs decreased substantially to ₹7.92 lakhs from ₹23.59 lakhs year-on-year.

Corporate Actions and Capital Structure

The Board approved several significant corporate developments during the meeting:

• Preferential Allotment: Received listing approval from BSE for 10,69,189 equity shares of face value ₹10 each at a premium of ₹56.95 per share • ESOP Implementation: Obtained listing and trading approval for 2,18,250 equity shares issued under the Employee Stock Option Plan • Bonus Issue Approval: Secured in-principle approval for bonus issue of up to 38,55,222 equity shares in 1:1 ratio

The paid-up equity share capital increased to ₹385.52 lakhs as of December 31, 2025, compared to ₹195.05 lakhs in the corresponding period of the previous year.

Consolidated Performance

On a consolidated basis, the company reported net profit of ₹21.46 lakhs for Q3FY26 compared to ₹11.82 lakhs in Q3FY25. Nine-month consolidated net profit reached ₹77.80 lakhs, though this was lower than ₹109.93 lakhs in the corresponding period of FY25. The consolidated results include the performance of subsidiary Arur Footwear Limited, in which the company holds a 50.10% stake.

Regulatory Compliance and Outlook

The financial results were prepared in accordance with Indian Accounting Standards and reviewed by statutory auditors Krishan Rakesh & Co. The Board also took note of quarterly compliance requirements under SEBI regulations and received the necessary compliance certificates from management. The company continues to operate as a registered non-banking financial company with its primary focus on interest-based revenue generation.

Bazel international has received listing approval from BSE Limited for its preferential issue of equity shares pursuant to loan conversion. The non-banking financial company announced this development through a regulatory filing dated February 5, 2026, marking a significant step in its capital restructuring process.

BSE Listing Approval Details

BSE Limited granted listing approval through letter No. LOD/PREF/SS/FIP/1577/2025-26 dated January 27, 2026. The approval covers the proposed issue of securities under Regulation 28(1) of SEBI LODR Regulations for preferential allotment pursuant to conversion of loan.

Allottee Details and Loan Conversion

The preferential issue involves conversion of loans from two corporate entities, both classified under the public-corporate category. The allotment structure demonstrates the company's approach to converting existing debt obligations into equity participation.

Regulatory Compliance Requirements

BSE has outlined specific compliance requirements that the company must fulfill before trading approval. The exchange emphasized adherence to SEBI ICDR Regulations and various procedural requirements for the preferential issue process.

Key compliance requirements include:

• Filing shareholding pattern in XBRL mode if change exceeds 2% of total paid-up share capital
• Obtaining confirmation letters from NSDL/CDSL regarding crediting shares to beneficiary accounts
• Securing listing approval from NSE if applicable
• Ensuring lock-in compliance for pre-preferential holdings

Trading Approval Timeline

According to SEBI circular SEBI/HO/CFD/PoD-2/P/CIR/2023/00094 dated June 21, 2023, Bazel International must apply for trading approval within seven working days from the listing approval date. The company must submit all required documents together, including depository confirmations and any applicable NSE approvals.

Previous In-Principle Approval

BSE had earlier granted in-principle approval for this preferential issue on November 24, 2025, under letter No. LOD/PREF/MV/FIP/1231/2025-26. The approval specified that shares would be issued at a price not less than Rs. 66.95 to non-promoters against loan conversion aggregating Rs. 7,15,82,171.

The exchange had advised the company to strengthen internal controls to monitor trades by proposed allottees and obtain undertakings confirming compliance with intra-day trading restrictions until allotment completion.